echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hesse acetic acid capofen net obtained the Drug Registration Certificate

    Hesse acetic acid capofen net obtained the Drug Registration Certificate

    • Last Update: 2020-09-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: Hesse is the fourth of its kind in China.
    August 18, Aso announced that its wholly-owned subsidiary, Liaoning Haisk, had recently received a net "Drug Registration Certificate" issued by the State Drug Administration for injectable carpofen.
    Synthesis is suitable for adult and child patients (three months and more): 1, empiric treatment of neutral granulocytes reduction, associated with fever patients suspected fungal infections;
    The role of this product in endoencephalitis, myelitis and meningitis caused by Candidosis infection has not been studied;
    has not yet studied the role of this product as the initial treatment of invasive tritomy disease.
    carpofen, a semi-synthetic lipid peptide compound synthesized by Glarea Lozoyensis fermentation products, is the first new antifungal drug of the echinococcosis class.
    has the characteristics of broad antibacterial spectrum, long half-life, high binding rate with human serum protein, fewer adverse reactions, good patient tolerance, etc. , is a clinically urgently needed anti-deep fungal infection drug.
    upon enquiry, merck Sharp and Dohme Corp. was approved by the FDA in 2001 for the market of Cancidas ®, 50mg and 70mg) for injections by Inc., and Forsyth ® merck Sharp and Dohme Corp. in 2007®
    Haisse is the fourth of its kind in China.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.